Candidate combinations are identified via a rigorous process of antimicrobial screening, informed by extensive in-house expertise and driven by potential for rapid delivery to the market.
Syntopix is able to bring an integrated approach, identifying antimicrobial synergies using industry standard techniques and predictive models of antimicrobial activity in the natural environment, followed up with extensive microbiological evaluation.
23/08/2010 07:00
AGREEMENT WITH GLOBAL CONSUMER PRODUCTS COMPANY
Syntopix signs an exclusive agreement with a world leading health and personal care brands company.
22/06/2010 07:00
Syntopix welcomes a new board member with Mike Townend joining as Non-executive Director
22/04/2009 13:13
03/02/2010 07:00
Syntopix announces a Directorate change with Tom Bannatyne joining as Chairman.
12/11/2009 07:00
Syntopix announces positive results for its lead dermatological compound SYN0126